A new Medicare pilot program that began July 1 is making GLP-1 medications more affordable for older adults. The initiative aims to increase access to these drugs, which can help manage overweight and obesity and improve overall health, but also comes with specific considerations for the senior population.
GLP-1 medications are a drug class that mimics the naturally occurring GLP-1 peptide hormone. These drugs affect appetite and blood sugar control. Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite and thirst, which can lead to malnutrition and dehydration. Older adults often take additional medications for conditions such as blood pressure or thyroid disorders; adding a GLP-1 may increase the risk of interactions or side effects.
"Older adults can have a higher risk of losing muscle and bone strength while losing weight," the article states. It emphasizes that "protein intake and strength training are critical while taking GLP-1 medications." Regular checkups are recommended to monitor nutrition, hydration, and medication management during treatment.
The article highlights that working with a physician can help older adults follow a safe treatment plan when using GLP-1s. This includes monitoring for potential risks like loss of muscle or bone tissue during weight loss—factors that may affect mobility, strength, and long-term independence.
Ohio State Health and Discovery addresses societal issues such as health equity and substance use; it also includes hospitals and outpatient facilities as part of its academic medical center. It seeks to advance health in Ohio and worldwide through innovations in research, education, patient care, and community involvement; extends efforts globally; offers resources on wellness topics including research advances; and focuses on health care research education—all according to the official website.
